AP
WST icon

Aspect Partners’s West Pharmaceutical WST Stock Holding History

Aspect Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.33K Buy
26
+24
+1,200% +$7.34K ﹤0.01% 290
2026
Q1 		$501 Hold
2
– – ﹤0.01% 657
2025
Q4 		$550 Buy
+2
New +$547 ﹤0.01% 672
2024
Q2 		– Sell
-1
Closed -$396 – 582
2024
Q1 		$396 Hold
1
– – ﹤0.01% 524
2023
Q4 		$352 Buy
+1
New +$354 ﹤0.01% 517

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Aspect Partners's WST Position: Q2 2026 in Review

Aspect Partners increased its West Pharmaceutical (WST) stake by 1,200% in Q2 2026, buying an estimated $7.34K and bringing the position to 26 shares worth $9.33K. The position accounts for ﹤0.01% of the portfolio, ranked #290.

Aspect Partners first reported a position in WST in Q4 2023 and has held it in 5 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Aspect Partners held 26 shares of West Pharmaceutical worth $9.33K as of Q2 2026.
  • Aspect Partners bought 24 West Pharmaceutical shares in Q2 2026, an estimated $7.34K.
  • West Pharmaceutical made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #290 holding.
  • Aspect Partners first reported a position in West Pharmaceutical in Q4 2023 and has held it in 5 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.